Valo Therapeutics Appoints Hemanshu Shah as Chief Business Officer

/PRNewswire/ -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, today announced...

Related Keywords

Helsinki ,Eteläuomen Läi ,Finland ,Mumbai ,Maharashtra ,India ,France ,French ,Hemanshu Shah ,Astellas Pharma ,Paul Higham ,Bristol Myers Squibb ,Rutgers University ,Vp Corporate Development At French ,University Of Mumbai ,Johnson ,University At Buffalo ,Chief Business Officer ,Global Marketing ,Global Therapeutic Head ,Infectious Diseases ,Innate Pharma ,Pharmaceutical Sciences ,Avalo Therapeutics ,